Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.920
+0.050 (2.67%)
At close: Mar 10, 2026, 4:00 PM EDT
1.900
-0.020 (-1.04%)
After-hours: Mar 10, 2026, 7:50 PM EDT

Bluejay Diagnostics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-6.85-7.72-9.95-9.3-3.49
Depreciation & Amortization
0.170.20.780.310.15
Stock-Based Compensation
00.020.190.430.07
Other Adjustments
0.040.3100.240.39
Changes in Inventories
----0.08
Changes in Accounts Payable
0.07-0.35-0.240.3-0.08
Changes in Accrued Expenses
0.15-0.7-0.030.340.2
Changes in Other Operating Activities
0.360.410.93-0.06-1.7
Operating Cash Flow
-6.05-7.82-8.31-7.74-4.37
Capital Expenditures
-0.17-0.31-0.7-1.2-0.02
Investing Cash Flow
-0.17-0.31-0.7-1.2-0.02
Short-Term Debt Issued
-2---
Short-Term Debt Repaid
-----0.01
Net Short-Term Debt Issued (Repaid)
-2---0.01
Long-Term Debt Issued
----4.5
Long-Term Debt Repaid
--2---0.29
Net Long-Term Debt Issued (Repaid)
--2--4.21
Issuance of Common Stock
8.3512.071.590.0318.89
Net Common Stock Issued (Repurchased)
8.3512.071.590.0318.89
Other Financing Activities
-1.26-1.85-0.48-0.02-0.56
Financing Cash Flow
7.0910.221.110.0122.53
Net Cash Flow
0.862.09-7.91-8.9318.14
Free Cash Flow
-6.23-8.13-9.02-8.94-4.39
FCF Margin
----3590.13%-
Free Cash Flow Per Share
-13.87-177.27-13160.21-14189.09-16486.23
Levered Free Cash Flow
-6.27-21.68-9.21-9.61-0.65
Unlevered Free Cash Flow
-6.37-7.91-9.57-9.63-4.59
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q